VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Classical swine fever virus E2 mutant vaccine
Vaccine Information
  • Vaccine Name: Classical swine fever virus E2 mutant vaccine
  • Target Pathogen: Classical swine fever virus
  • Target Disease: Classical swine fever, hog cholera
  • Vaccine Ontology ID: VO_0002954
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Pig
  • E2 gene engineering:
    • Type: Gene mutation
    • Description: This E2 mutant is from Classical swine fever virus (Maurer et al., 2005).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Oronasal immunization
Host Response

Pig Response

  • Persistence: An E2 mutant is attenuated in swine (Maurer et al., 2005).
  • Efficacy: An E2 mutant induced significant protection in swine from challenge with wild type CSFV (Maurer et al., 2005).
References
Maurer et al., 2005: Maurer R, Stettler P, Ruggli N, Hofmann MA, Tratschin JD. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine. 2005; 23(25); 3318-3328. [PubMed: 15837238].